Professor, Stanford University, USA Howard Hughes Medical Institute |
|
|
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, USA Board Director, Oligonucleotide Therapeutics Society |
|
|
|
|
|
|
|
Stanley CROOKE, MD, PhD
Founder, CEO and Chairman of the Board Ionis Pharmaceuticals, USA |
|
|
Craig MELLO, PhD
Professor, University of Massachusetts Howard Hughes Medical Institute, USA Nobel Prize in Physiology or Medicine (2006) |
|
|
|
|
|
|
Director, AstraZeneca, UK |
|
|
Professor, the University of Tokyo, Japan |
|
|
|
|
|
|
Jan GORODKIN, PhD
Professor, University of Copenhagen Director, Center for Non-Coding RNA in Technology and Health, Denmark |
|
|
Senior Group Leader Wellcome Trust Sanger Institute, UK |
|
|
|
|
|
|
Professor, University of Chicago, USA Howard Hughes Medical Institute |
|
|
Erik SONTHEIMER, PhD
Professor, University of Massachusetts Medical School, USA |
|
|
|
|
|
|
Professor, University of British Columbia, Canada |
|
|
Professor, Muséum National d’Histoire Naturelle MNHN-CNRS-INSERM, France |
|
|
|
|
|
|
Professor, Seoul National University Director, Institute for Basic Science, South Korea |
|
|
Associate Professor Purdue University, USA |
|
|
|
|
|
|
VP and Head of Research, RNA Therapeutics Roche, Denmark / Switzerland |
|
|
Professor, Weizmann Institute of Science, Israel Nobel Prize in Chemistry 2009 |
|
|
|
|
|
|
Professor, Senior Director, Sanofi, Germany Founding Director, COMPACT Consortium |
|
|
Professor, University of Rochester Medical Center School of Medicine and Dentistry, USA |
|
|
|
|
|
|
Judy LIEBERMAN, MD, PhD
Professor, Program Chair, Harvard Medical School American Academy of Arts & Sciences, USA |
|
|
|
Copyright(C) Canton Nuleic Acids Forum